Australia News All stories

Sports Entertainment Group (ASX:SEG) has upgraded its financial year 2026 guidance with expected underlying earnings of $18 million.

Iceni Gold (ASX:ICL) executed an agreement with Gold Fields for up to $10 million in exploration spending.

Sprintex (ASX:SIX) has secured new and upgraded processing equipment orders from Mest Water valued at $42.4 million.

Euroz Hartleys (ASX:EZL) has entered into a binding agreement to sell its capital markets business to BMO Financial Group.

MLG Oz (ASX: MLG) secured a $70 million integrated mining and crushing contract at the Pioneer Dome Lithium Project.

Stakk (ASX:SKK) expects to report its first operating profit for the 2026 financial year alongside a projected FY27 revenue of approximately $21.8 million.

Celsius Resources (ASX:CLA) has executed a binding agreement to sell its 95% interest in the Opuwo Cobalt-Copper Project for US$15 million.

Collins Foods (ASX:CKF) reported an 8.6% revenue increase to a record $1.60 billion for fiscal year 2026.

The Australian government confirmed the introduction of a package of cost-of-living measures starting July 1.

Air New Zealand (ASX:AIZ) appointed Kris Cudmore as its new CFO starting on Aug. 3.

The Federal Court fined Mercer Super $10.3 million after compliance failures left regulators unaware of serious member issues.

An Australian parliamentary committee recommends an ACCC inquiry into Apple (NASDAQ:AAPL) over its payment network restrictions.

Airtasker (ASX:ART) has agreed to early cash settlement of two A$5 million media partnership notes issued to oOh!media (ASX:OML) and ARN Media (ASX:A1N), paying A$5,463,847 to oOh!media and A$5,357,668 to ARN instead of converting the notes and accrued coupons into discounted equity.

BCAL Diagnostics (ASX:BDX), an Australian healthcare company focused on early cancer detection, has secured firm commitments for a further A$4.9 million under its existing A$10 million convertible note facility, with the additional funds to be drawn down as required.

HITIQ (ASX:HIQ) has received firm commitments from professional and sophisticated investors to raise A$1.4 million before costs through a two‑tranche private placement of 200,000,000 new shares at A$0.007 per share, with one free unlisted option attached to each placement share.

Karoon Energy (ASX:KAR) has restarted production from the SPS‑92 well at the Baúna Project in Brazil after replacing the well’s electrical submersible pump, with SPS‑92 now producing about 8,600 barrels of oil per day and total Baúna output at roughly 20,500 bopd before natural decline.

Silex Systems (ASX:SLX; OTCQX:SILXY) has completed construction of the SILEX Quantum Silicon (Q‑Si) Production Plant, described as the world’s first laser‑based silicon enrichment facility, at its site in Sydney and has begun commissioning work on the plant’s laser system and first two enrichment reactors.

FDC Consolidated Holdings (ASX:FDC), the holding company for national construction and fitout business FDC, has lodged its IPO prospectus with ASIC and applied to list on the ASX, targeting a $400 million raising through the issue of 133.6 million fully paid shares at $3.00 each for an implied market capitalisation of $969 million at listing.

Adherium (ASX:ADR), a digital respiratory management company and developer of the US FDA‑cleared Hailie Smartinhaler, has secured US$1.65 million in short‑term funding via an unsecured loan facility from its major shareholder Trudell Medical to support working capital requirements.

Mercer Super, one of Australia’s largest super funds with about $80 billion in assets and more than one million members, has been ordered by the Federal Court to pay $10.3 million in penalties for systemic failures to report investigations into serious member service issues to ASIC.

Atlas Arteria (ASX:ALX) has lodged a sixth supplementary target’s statement with ASIC and ASX, reiterating its independent directors’ unanimous recommendation that securityholders reject IFM Global Infrastructure Fund’s off‑market cash offer for Atlas Arteria stapled securities.

Former company director Trent Bowden has pleaded guilty in the Perth Magistrates Court to three charges of dishonestly using his position as director of Trent Bowden Trading Pty Ltd to gain an advantage for himself, in connection with more than $1.5 million of investor funds.

CSL Limited (ASX:CSL) has reported that the European Medicines Agency’s CHMP has issued an opinion recommending the revocation of the EU marketing authorisation for TAVNEOS (avacopan), an in‑licensed therapy sold in EU and EEA markets by CSL Vifor affiliates.

Neuren Pharmaceuticals (ASX:NEU) says the European Medicines Agency’s CHMP has adopted a positive opinion, after re‑examination, recommending the European Commission grant marketing authorisation for DAYBU (trofinetide) to treat neurobehavioral symptoms of Rett syndrome in adults and children aged five and over.